ArticleFrontiers in medicine2026
Case Report: Vascular abdominal pain in systemic sclerosis-chronic mesenteric ischemia from high-grade superior mesenteric artery stenosis with coexisting aortomesenteric narrowing.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Gastrointestinal involvement is common in systemic sclerosis (SSc), but severe abdominal pain should not be attributed automatically to dysmotility or malabsorption. We report a 72-year-old woman with long-standing limited cutaneous SSc who developed recurrent severe abdominal pain, progressive oral-intake limitation, and marked weight loss. Abdominal computed tomography angiography showed high-grade calcified stenosis at the superior mesenteric artery (SMA) origin together with a reduced aortomesenteric angle of 17 degrees and a distance of 4.7 mm, creating a coexisting SMAS-like anatomic context. After multidisciplinary review, endovascular balloon angioplasty and stent implantation were performed because the SMA lesion was considered a major treatable vascular contributor in a frail patient at high operative risk. Severe pain improved and oral intake advanced after revascularization, but portal-hypertensive disease, partial small-bowel obstruction, severe malnutrition, and SSc-related gastrointestinal involvement remained plausible concurrent contributors. Follow-up CTA in March 2024 showed post-stent changes without recurrent acute mesenteric ischemia, but long-term stent-patency and nutritional-recovery data were limited. This case does not establish a new causal mechanism; rather, it illustrates a structured approach to severe abdominal pain in SSc that distinguishes a treatable vascular lesion from SMAS-like anatomy and other nonvascular abdominal disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.